Taurus Asset Management’s Chembio diagnostics, Inc. CEMI Stock Holding History

Taurus Asset Management’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-12,500	Closed	-$76K	–	109
2017 Q2	$76K	Sell	12,500 -4,500	-26%	-$28.1K	0.01%	95
2017 Q1	$90K	Hold	17,000	–	–	0.01%	90
2016 Q4	$116K	Sell	17,000 -5,000	-23%	-$34.6K	0.02%	87
2016 Q3	$163K	Sell	22,000 -5,000	-19%	-$36K	0.03%	91
2016 Q2	$221K	Sell	27,000 -11,335	-30%	-$88.3K	0.04%	85
2016 Q1	$230K	Buy	+38,335	New	+$198K	0.04%	89

Other funds holding CEMI

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCA

Benchmark Capital Advisors New York $101M AUM 0.8% 1-Year Est. Return

Taurus Asset Management's CEMI Position: Q3 2017 in Review

Taurus Asset Management sold out of Chembio diagnostics, Inc. (CEMI) in Q3 2017, closing a stake of 12,500 shares — an estimated $76K sold.

Taurus Asset Management first reported a position in CEMI in Q1 2016 and held it in 6 quarters. The position peaked at $230K in Q1 2016. 21 funds tracked by Wall St. Rank hold CEMI as of Q3 2017.

Taurus Asset Management reported no remaining Chembio diagnostics, Inc. position as of Q3 2017 after selling out during the quarter.
Taurus Asset Management sold 12,500 Chembio diagnostics, Inc. shares in Q3 2017, an estimated $76K.
Taurus Asset Management first reported a position in Chembio diagnostics, Inc. in Q1 2016 and held it in 6 quarters.
Taurus Asset Management's Chembio diagnostics, Inc. position peaked at $230K in Q1 2016.
21 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q3 2017.

Based on Taurus Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.